Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
AstraZeneca speeds R&D decision making with cutting-edge life sciences technology
Facebook
Facebook
Twitter
Twitter
LinkedIn
LinkedIn
Email
Email
0 Comments
Comments
Users see at-a-glance, side-by-side comparisons of adverse events for drugs already on the market or in clinical trials. They get a deeper understanding of the drugs and how they are being targeted for diseases by segment. The comparisons visualize the level of current research and development activity around an indication, whether by company or mechanism of action, together with information on ongoing clinical trials.
0 Comments
View Comments
- People:
- Wendy Hamilton
- Places:
- PHILADELPHIA, PA
Press Release
Author's page
Related Content
Comments